This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Find detailed information about this topic here.) Check back soon for articles detailing information in the report from these departments. For Illinois News Joint reviews, visit here.
The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
In the fast-paced, data-driven world of the cannabis industry, partnerships are crucial to success. We thank our partners at Headset for collaborating on the white paper to provide a wealth of information that people can trust to make informed business decisions in our evolving marketplace.”
Please visit www.rocnorml.org for more information about how you can get involved and follow ROC NORML on Facebook and Twitter. . Furthermore, when we look at states that haven’t legalized cannabis for adult-use, take Alabama for example, we see similar trends related to number of vehicle related fatalities.
The MED is excited to announce a new data dashboard that will provide an increased array of data collected and analyzed by the Division and will house the quarterly marijuana market updates going forward. The MED will now increase their data reporting to four times a year from the previous twice-a-year updates.
Leaf Data Systems Update. On this page, you’ll find the previously announced Board Interim Policies, approved colors and shapes, links to the recent webinar and accompanying PowerPoint, and other useful information. Here’s the Table of Contents. Winter Edition 2019 – Cannabis. Board Approves Jan. Pesticide Disclosures.
reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. Can a Company Be Liable for an Accidental Data Breach?
Marketing, labeling and sales : How should consumers be informed about the risks associated with such products (e.g., What specific risks should consumers be informed about? For a complete list of questions and topics identified by the FDA, see here. directions for use, warnings)?
In the past year, CANNRA has launched more than a dozen different special committees for state cannabis regulatory staff to share knowledge and work towards regulatory best practices on a range of topics: Licensing, Compliance, and Enforcement. Public Health and Data Monitoring. Social and Economic Equity. Medical Use and Research.
These methods may include: regular consumption inhalation oral administration local treatment via topical products. The results were very positive and showed the safety and effectiveness of the topical CBD. The interaction of cannabis with acne has quite limited medical data and there are few conflicting hypotheses.
This report offers an overview of the current regulatory situation for medical and recreational cannabis in 54 selected countries around the world, and also includes a detailed database that is easy to use and allows you to filter the information. Key Topics Covered: Introduction. For more information about this report visit [link].
Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward. I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. 22 – “High Risk?
There is a lot of information out there about the cannabis industry and its regulatory structure, but not much is known about consumers,” said Zach Knowling, vice president at Quinn Thomas, in an email. Indeed, the survey data show that recreational-cannabis consumers look pretty much like the average American.
Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Missing and Vague Information. The Study Appears to Have a Few Flaws.
Topical CBD Pain-Relief Receives FDA Product Listing Certification. Elixicure, an over-the-counter (OTC) CBD-infused topical pain-relief cream marketed for treating inflammation, aches, and pains, has received product listing certification from the Food & Drug Administration (FDA).
Question: Can you please share any information on the bioavailability of THC (aka RSO) suppositories? As strange as it may sound, there is very little data evaluating the effects of cannabis infused suppositories. Most of the existing data suggest that THC is not well absorbed from the rectum, or not absorbed at all.
While we’re on the topic of dramatic legal changes, it’s probably a good idea to talk about a California privacy law that’s about to take effect and require many cannabis and hemp companies across the nation to dramatically change their business practices—the California Consumer Privacy Act (or “CCPA”).
Kannapedia also displays valuable information for breeders and cultivators who are interested in establishing prior art as a means to protect their genetics from any future patents. Patent Law is a complicated topic. Let’s explore some of the common questions we have seen around the topic. Can you patent illegal things?
Building the bridge between brands and the marketplace through testing and the importance of good data. a topical versus a suppository, can only be understood and captured by the producers themselves. Shannon Swantek, CQA, Principal Scientist, CEO, Enlightened Quality Analytics. .
In response to Senator Wyden and other stakeholders’ demands, FDA Acting Chief Information Officer, Amy Abernethy, recently announced on Twitter that: [FDA] is expediting its work to address the many questions about cannabidiol (CBD). Four days before the deadline, over three thousand comments had been published on the public docket.
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.
Key Topics Covered: Executive Summary. For more information about this report visit [link]. ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. Hemp and CBD. Extracts as Finished Products. Finished Products Containing CBD and Extracts. Medical Cannabis.
With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA. FDA is re-opening the docket to obtain information on “full spectrum” and “broad spectrum” hemp extracts, and how they compare to CBD isolate products.
Key Topics Covered: Executive Summary. For more information about this report visit [link]. ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. Hemp Plant. Extracts as a Finished Product. Finished Products Containing CBD and Extracts. Enforcement Actions.
INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. For more information, visit www.inmedpharma.com. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.
Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Gen Z is drinking far less alcohol, and many of them don’t use it at all.
The information for each competitor Incudes: Company Profile. Main Business Information. Historical Data: from 2016 to 2020. Forecast Data: from 2021 to 2026. Key Topics Covered: Chapter 1 Executive Summary. Data Sources. Main Business and CBD Oil Information. SWOT Analysis. Market Share. Assumptions.
(TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce the launch of HempFusion Ingestible and Topical CBD products into nearly 50 retail locations of a major Arizona grocer.
The provision — which seeks to increase the state’s supply of medical cannabis — specifies that contaminated products can be resold as topical goods after undergoing restoration inside an independent laboratory. A total of 548.468 patients were enrolled in Pennsylvania’s medical cannabis program as of June 3; based on DOH data.
(“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, has released its first data and insights report, titled ‘Cannabis in America’. According to Weedmaps’ orders data, orders in H1 2021 increased by 55%, compared to H1 2020.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Key Topics Covered: 1. Market drivers. Market challenges.
With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA. FDA is re-opening the docket to obtain information on “full spectrum” and “broad spectrum” hemp extracts, and how they compare to CBD isolate products.
HempFusion’s OTC (Over-the-Counter)) Pain Relief Cream will be added to approximately 400 stores and HempFusion’s Ingestible and Topical CBD products will now be available in 75 targeted stores. For more information, visit www.hempfusion.com. HempFusion‘s Co-Founder and Chief Executive Officer. ABOUT HEMPFUSION.
The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including online and offline resources and data, specialised legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground profession.
The information for each competitor includes: Company Profile. Main Business Information. Historical Data: from 2016 to 2020. Forecast Data: from 2021 to 2026. Key Topics Covered: Chapter 1 Executive Summary. Data Sources. For more information about this report visit [link]. SWOT Analysis.
A replay will be available from the Investor Relations section of HempFusion’s website at HempFusion.com/corporate-information. Use Entry Code: 746381. To join the webcast, please visit [link]. ABOUT HEMPFUSION. HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition.
The news outlet used data from Headset to explain that Gen Z women who purchased cannabis grew by 151%, with the Gen Z men sitting at a 118% increase in legal purchases. According to the Headset data, flower purchases dominate in both genders but women tend to navigate towards pre-rolled joints, edibles, and beverages more than men.
“A significant issue preventing the consideration of cannabinoid medicine by healthcare professionals is that the topic is not typically included in the medical school curriculum,” comments Dr. Mark Ware, Chief Medical Officer, Canopy Growth. For more information visit www.canopygrowth.com. ABOUT SPECTRUM THERAPEUTICS.
The relationship between cannabis consumption, mental health, and suicide has been a hot topic for both those for and against cannabis legalization. Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization.
The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston.
It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. I’ve seen it as flower, I’ve seen it as topical, which has anti-bacterial and anti-psoriatic effects. You can get it as a topical, as I’ve mentioned. You can get it as flower if you want to vaporize it. I really enjoy it.
In this episode of The Cannabis Enigma podcast, Matthew unpacks how that lack of information negatively impacts the industry. For myself, as a cannabis professional who was pretty ambitious to, like, move up the corporate ladder, I saw that there was an absence of good information. Terminology like ‘indica-sativa hybrids.’
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content